Business · 24/04/2023Updated: 10/17/2026 · 1 min read
FDA Awards Priority Review Voucher to JOENJA Sponsor
Summary
The FDA has issued a priority review voucher to the sponsor of JOENJA, a rare pediatric disease product approved on March 24, 2023, following a review of the product's eligibility under the FD&C Act and FDASIA.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →